NEOSTIGMINE METHYSULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neostigmine Methysulfate, and when can generic versions of Neostigmine Methysulfate launch?
Neostigmine Methysulfate is a drug marketed by Avet Lifesciences and is included in one NDA.
The generic ingredient in NEOSTIGMINE METHYSULFATE is neostigmine methylsulfate. There are nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Neostigmine Methysulfate
A generic version of NEOSTIGMINE METHYSULFATE was approved as neostigmine methylsulfate by FRESENIUS KABI USA on January 8th, 2015.
Summary for NEOSTIGMINE METHYSULFATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NEOSTIGMINE METHYSULFATE at DailyMed |
Pharmacology for NEOSTIGMINE METHYSULFATE
| Drug Class | Cholinesterase Inhibitor |
| Mechanism of Action | Cholinesterase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for NEOSTIGMINE METHYSULFATE
US Patents and Regulatory Information for NEOSTIGMINE METHYSULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | NEOSTIGMINE METHYSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 208230-001 | Nov 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Avet Lifesciences | NEOSTIGMINE METHYSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 208230-002 | Nov 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
